Document is current
Any future updates will be listed below
-
Authors
Gong, Li
Lu, Xinyu
Ma, Na
Lu, Tao
Gong, Yuhong
Hao, Liwei
Xu, Weikang
Zhang, Qianbing
Chen, Xiaolan
Mo, Qinglin
Tan, Jiexing
de Paula Lemos, Henrique
Speechley, Alexander
Tu, Wenwei
Cai, Jianpiao
Huang, Lei
Zhu, Wei
Wu, Sha
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81802449)
National Natural Science Foundation of China (82073360)
National Natural Science Foundation of China (82073165)
Guangdong Basic and Applied Basic Research Foundation (2023A1515012169)
Guangdong Provincial Natural Science Foundation (2214050008966)
Outstanding Youth Development Scheme of Nanfang Hospital, Southern Medical University (2020J004)
Hospital Dean Foundation of Nanfang Hospital, Southern Medical University (2020NF0016)
14th Five-year high level specificality construction project in Foshan (FSGSP145033)
- License Information
-
More Information
Article History
Received: 16 March 2025
Accepted: 24 February 2026
First Online: 29 March 2026
Declarations
:
: Ethics approval and consent to participate. After deliberation by the Ethics Committee of Changzhou Seventh People’s Hospital, the design and plan of this research fully considered the principles of safety and fairness, and the research content fully considered the requirements of patient rights and ethics, in accordance with the Helsinki Declaration. There are no conflicts of interest in the research content and results. The study was granted ethics committee approval by Changzhou Seventh People’s Hospital on 8 November 2021, with ethical no. LC2021. After deliberation by the Nanfang Hospital Animal Ethic Committee on the animal protocol, all animal experimentation processes comply with the regulations of China and Southern Hospitals regarding the health and welfare of experimental animals, and in accordance with the International Council for Laboratory Animal Science (ICLAS). The study was granted approval by the Nanfang Hospital Animal Ethic Committee on 11 July 2020, with ethical no. NFYY-2020-0719.
: Not applicable.
: Lei Huang is the founder and directed of Zeal BioScience Group Limited.
